This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
References 1. Biabco P, Robey PG, Simmons Pj. Mesenchyal Stem Cells:Revisiting History,concepts, and assays.Cell Stem Cell 2008;2:313-319. 2. Xin WEI , XUe YANG ,Zhi peng HAN,Fang-fang Qu,Li Shao and Yu-fang Shi. Mesenchymal stem cells: a new trend for cell therapy.Acta Pharmacologia Sinica 2013;34:747-754. 3. Oubari F, Amirizadeh N, Mohammadpour H, Nakhlestani M, Nikougoftar Zarif M. The important role of Flt3-l in exvivo expansion of hematopoietic stem cells following co-culture with mesenchymal stem cells. Cell Journal 2015;17. 4. Oubari F, Nikougoftar Zarif M, Amirizadeh N,Shaiegan M,Atarodi A,Nakhlestani et al.Isolation and expansion of Mesenchymal Stem cells from placenta. Sci J Iran Blood Transfus Organ 2013; 10: 222-230.
5. Amit N Patel, Jorge Genovese. Potential clinical application of adult human mesenchymal stem cell (Prochymal) therapy.Stem Cell Cloning: Advances and Applications 2011:4, 61-72. 6. Gebler A, Zabel O, Seligar B. The immunomodulatory capacity of Mesenchymal stem cells. Trends Mol Med 2012;2:128-34. 7. Nayoun Kim and Seok-Goocho. Clinical application of mesenchymal stem cells.Korean J Intern Med 2013 ;28:387-402. 8. In t Anker PS, Scherjon SA,Kleijburg-van der Keur C , de Groot-Swing GM , Class FH , Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 2004;22:1338-45. 9. Ulrich C, Rolauffs B, Abele H,Bonin M , Nieselt K , Hart ML, et al. Low osteogenic differentiation potential of placenta-derived mesenchymal stromal cells correlates with low expression of the transcription factors Runx2 and Twist2. Stem Cells Dev 2013;22:2859-72. 10. Carmen L Insausti , Blanquer M , Ana M, Castellanos G and Moraleda JMet al.Amniotic membrane derived stem cells: immunomodulatory properties and potential clinical application. Stem Cells Cloning 2014;7 :53-63. 11. Shihua Wang , Xuebin Qu and Robert Chunhua Zhao.Clinical application of mesenchymal stem cells. Journal of hematology &onchology 2012; 5:19. 12. Tzaribachev N, Vaegler M, Schaefer J, Reize P, Rudert M, Handgretinger R , et al. Mesenchymal stromal cells:a novel treatment option for steroid induced avascular osteonecrosis.Isr Med Assoc J 2008;10:232-4. 13. Kharaziha P, Hellstrom PM, Noorinayer B, Farzaneh F ,Aqhajani K ,Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection:a phase I-II clinical trial . Eur J Gastroenterol Hepatol 2009; 21:1199-205. 14. Lu D , Chen B , Liang Z , Deng W,Jiang Y , Li S, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow
derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double
blind , randomixed , controlled trial . Diabetes Res Clin Pract 2011; 92:26-36. 15. Rasulov MF, Vasilchenko AV, Onishchenko NA,Krasheninnikov ME, Kravchenko VI, Gorshenin TL, et al . First experience of the use bone marrow mesenchymal stem cells for the treatment of a patient with deep skin burns. Bull Exp Biol Med 2005;139:141-4. 16. Dai Lj, Moniri MR, Zheng ZR,Zhou JX, Rayat J , Warnock GL. Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett 2011 ;305:8-20. 17. Smith H, Whittall C, Weksler B, Middleton JFS . Chemkines stimulate bidirectional migration of human mesenchymal stem cells across bone marrow endothelial cells. Stem Cells Dev 2012 ;21:476-486.
18. Parolini O, Alviano F, Bagnara GP, Bilic G, Magatti M, Buhring HJ, et al. Concise review :isolation and characterization of cells from human term placenta: outcome of the first international Workshop on placenta Derived
derived Stem Cells. Stem Cells 2008 ;26:300-
311. 19. Ivanova Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E , Dimitrov R , et al. HLA-G expression is up regulated by progesterone in mesenchymal stem cells.Am J Reprod Immunol 2009 ;62:25-33. 20. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E , Ringden O.HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.Exp Hematol 2003;31:890-6. 21. IIancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 2009 ; 30:2-10. 22. MiKi T, Strom SC. Amnion
Derived Pluripotent /Multipotent Stem Cells. Stem Cells Rev 2006; 2:133-42. 23. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH. Immunomodulation by Mesenchymal Stem Cells : A Potential Therapeutic Strategy for Type I Diabetes. Diabetes 2008; 57:1759-67. 24. Sotiropoulou PA, Perez SA,Gritzapis AD, Baxevanis CN, Papamichail M.Interaction Between Human Mesenchymal Stem Cells and Natural Killer Cells. Stem Cells 2006 ; 24:74-85. 25. Magatti M , De Munari S, Vertua E, Nassauto C , Albertini A , Wengler GS, et al.Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant 2009;18:899-914. 26. Magatti M , De Munari S , Vertua E, Gibelli L , Wengler GS , Parolini O .Human amnion mesenchyme harbors cells with allogeneic T- cell suppression and stimulation capabilities.Stem Cells 2008; 26:182-92. 27. Roelen DL,van der Mast BJ, int Anker PS, Kleijburg C, Eikmans M , Beelen Ev, et al. Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells. Hum Immunol 2009; 70:16-23. 28. Li C, Zhang W, Jiang X, Mao N.Human placenta
derived mesenchymal stem cells inhibit proliferation and function of allogenic immune cells. Cell Tissue Res 2007; 330:437-46. 29. Macotonia SE, Hosken NA, Litton M, Vieira P , Hsieh CS , Culpepper JA, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ Tcells.J Immunol 1995;154:5071-9. 30. Chen PM, Yen ML, Liu Kj, Sytwu HK, Yen BL. Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells.J Biomed Sci 2011;18:49. 31. Sivanathan KN, Gronthos S , Rojas-Canales D, Thierry B , Coates PT . Interferon-Gama Modification of Mesenchymal Stem Cells: Implication of Autologous and Allogenic Mesenchymal Stem Cell Therapy in Allotransplantation. Stem Cells Rev 2014;10:351-75. 32. Nasef A, Mathieu N, Chapel A, Johanna F, Francois S, Mazurier C, et al. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G . Transplantation 2007; 84:231-7. 33. Bernardo ME, Locatelli F and E.Fibbe W. Mesenchymal stromal cells. Hematopoietic Stem Cells VII: Ann N Y Acad Sci 2009; 1176: 101-117. 34. Krampera M, Losmi L , Angeli R, Pasini A , Liotta F , Andreini A, et al . Role for interferon
gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006;24:386-98.
Gomes I ,Elvira G, Zapata AG, Lamana ML , Ramirez M ,Cstro JG, et al.
Mesenchymal stem cell : biological properties and clinical applications. Expert Opin Biol Ther 2010;10:1453-68. 36. Sato K, Ozaki K, Mori M,Ozawa K. Mesenchymal stromal cells for graft
versus
host
disease: basic aspects and clinical outcomes. J Clin Exp Hematop 2010;50:79-89. 37. Tolar J, Le Blank K, Keating A, Blazar BR . Concise review: hitting the right spot with mesenchymal stromal cells. Stem Cells 2010; 28:1446-55. 38. Kenneth W , Liechty KW, Tippi C , Mackenzie TC, Shaaban AF,Antoneta Radu, et al. Human mesenchymal stem cells engraft and demonstrate site
specific differentiation after in utero transplantation in sheep. Nat Med 2000 ;6:1282-6. 39. Lama VN, Smith L, Badri L, Flint A , Murray S , Wang Z , et al.Evidence for tissue
resident mesenchymal stem cells in human adult lung from studies of transplanted allograft . J Clin Invest 2007 ; 117: 989 996. 40. Horwitz EM, Gordon PL , Koo WK, Marx JC, Neel MD, McNall RY, et al. Isolated allogeneic bone marrow
derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfect :Implications for cell therapy of bone . Proc Natl Acad Sci USA 2002 ;99:8932-7. 41. Kawada H, Fujita J, Kinjo K,Matsuzaki Y , Tsuma M, Miyatake H, et al.Nonhematopoietic mesenchymal stem cell can be mobilized and differentiate into cardiomyocyte after myocardial infarction . Blood 2004;104:3581-7. 42. Cheng Z, Ou L, Zhou X, Li F , Jia X , Zhang Y , et al.Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infracted myocardium improves cardiac performace. Mol Ther 2008;16:571-9. 43. Ko IK, Kim BG, Awadallah A,Mikulan J, Lin P, Letterio JJ, et al.Targeting improves MSC treatment of inflammatory bowel disease . Mol Ther 2010;18:1365-72. 44. Shi M , Li J, Liao L,Chen B, Li B , Chen L , et al. Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment : role in homing efficiency in NOD/SCID mice. Haematologica 2007; 92:897-904. 45. Ren G, Zhao X, Zhang L, Zhang J, LHuillier A , Ling W , et al.Inflammatory cytokine- induced intracellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol 2010;184:2321-8. 46. Studeny M, Marini FC, Champlin RE, Zompetta C , Fidler IJ, Andreeff M . Bone marrow
derived mesenchymal stem cells as vehicles for interferon beta delivery into tumors. Cancer Res 2002;62:3603-8. 47. Ren C, Kumar S , Chanda D, Kallman L, Chen J, Mountz JD, et al.Cancer gene therapy using mesenchymal stem cells expressing interferon- beta in a mouse prostate cancer lung metastasis model. Gene Ther 2008; 15:1446-53. 48. Seo SH , Kim KS, Park SH, Suh Y S , Kim S J , Jeun S-S , et al. The effects of mesenchymal stem cells injected via different routes on modified IL-12
mediated antitumor activity . Gene Ther 2011;18:488-95. 49. Loebinger MR, Eddaoudi A, Davies D, Janes SM. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 2009 ;69:4134-42. 50. Ren C, Kumar S, Chanda D,Chen J, Mountz JD , Ponnazhagan S.Therapeutic potential of mesenchymal stem cells producing interferon-
in a mouse melanoma lung metastatasis model.Stem Cells 2008 ;26:2332-2338. 51. Schnabel LV, Lynch ME, van der Meulen MCH , Yeager A E , Kornatowski MA , Nixon AJ . Mesenchymal stem cells and insulin
mesenchymal stem cells improve structural aspects of healing in equine flexor digitorum superficial tendons. J Orthop Res 2009; 27:1392-1398. 52. Tyndall A, Uccelli A. Miltipotent mesenchymal stromal cells for autoimmune diseases :teaching new dogs old tricks. Bone Marrow Transplant 2009;43:821-8. 53. Kim J, Hematti P. Mesenchymal stem cell- educated macrophages : a novel type of alternatively activated macrophages. Exp Hematol 2009;37:1445-53. 54. Kebriaei P, Isola L , Bachceci E, Holland K , Rowley S , McGuirk J , et al. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft
versus-host disease . Biol Blood Marrow Transplant 2009;15:804-11. 55. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008 ;371:1579-86. 56. Ciccocioppo R , Bernardo ME, Sgarella A, Maccario R , Avanzini MA ,Ubezio C , et al . Autologous bone marrow derived mesenchymal stromal cells in the treatment of fistulising Crohn s disease. Gut 2011;60:788-98. 57. Connick P, Kolappan M, Patani R, Scott MA , Crawley C, He XL , et al. The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics : an open
label pre-test:post-test study with blinded outcome assessments. Trials 2011;12:62. 58. Hanmou O, Houkin K, Matsunaga T,Niitsu Y, Ishiai S , Onodera R , et al.Intravenous administration of auto serum expanded autologous mesenchymal stem cells in stroke. Brain 2011 ;134:1790-807. 59. Zhang D , Zhang L , Shi H , Chen X , Wan Y , Zhang H , et al. Suppresion of Peritoenal Tumorgenesis by Placenta-Derived Mesenchymal Stem Cells Expressing Endostatin on Colorectal Cancer.Int J Med Sci 2014; 11:870-879. 60. Serakinci N , Fahrioglu U, Christensen R . Mesenchymal stem cells ,cancer challenges and new directions. Eropean journal of Cancer 2014;50:1522-1530. 61. Farini A, Sitzia C , Erratico S , Mereqalli M , Torrente Y. Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases.Stem cells Int 2014 ; 2014 : 306573,11pages. 62. Mi Z, Bhattacharya SD, Kim VM, Guo H, Talbot Lj, Kuo PC. Osteopontin promotes CCL5-mesenchymal stromal cell - mediated breast cancer metastasis. Carcinogenesis 2011;32:477-87. 63. Karnoub AE, Dash AB, Vo AP,Sullivan A, Brooks MW , Bell GW, et al.Mesenchymal stem cell within tumor stroma promote breast cancer metastasis.Nature 2007;449-557-63. 64. Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.Scince 2005;307:57-62. 65. Gao J, Dennis JE, Muzic RF, Lundberg M,Caplan AI. The dynamic in vivo distribution of bone marrow derived mesenchymal stem cells after infusion. Cell Tissues Organs 2011;169:12-20. 66. Moniri MR, Dai L-J and Warnoc. The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells. Cancer Gene Therapy 2014;21:12-23. 67. Liu J, Liu XF, Wan L, Li YP, Li SF, Zheng LY, et al. Suppression of human peripheral blood lymphocyte proliferation by immortalized mesennchymal stem cells dervived from bone marrow of Banna Minipig inbred line. Transplant Proc 2004;36:3272-5. 68. Karimi MM , Adib M, Hashemi Beni B,Alipour R , Hassanzadeh A. Immonomodulatory Properties of Human Bone Marrow Mesenchymal Stem Cells on T Lymphocyte proliferation. Journal of Isfahan Medical School 2012; 29. [In Persian]
69. Kampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone Marrow inhibit the response of Naïve and memory antigen specific T cells to their cognate peptid. Blood 2003;101:3722-9. 70. Augella A , Tasso R, Negrimi SM , Amateis A, Indiveri F , Cancedda R , et al.Bone marrow mesenchymal stem cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005;35:1482-90.